Biocidal products manufactured in or imported into the European Union (EU) must be authorised for compliance with the requirements of the EU Biocidal Products Regulation (BPR) and any relevant national legislation before being placed on the market. Here, Karen Rossington and Siobhan Murphy from Contec guide readers through the implications on life science cleanroom users.
Checklist
Biocidal products have been regulated in the EU by the EU Biocidal Product Regulation 528/2012 (BPR) since 1 September 2013.
The aim of the BPR is to improve the consistency of the biocidal products available in the EU and ensure a high level of protection for humans and the environment via a two-stage process of active substance approval followed by biocidal product authorisation. The provisions of the BPR set out to harmonise the market at EU level and simplify the approval of active substances and authorisation of biocidal products. The BPR acts directly in all EU Member States, meaning that local legislation does not need to be created to implement the requirements.